I have a problem with the concept of false discovery rate. Assuming I have a panel of 50 anticancer drugs for which their IC50 values are reported for 30 cell lines. On the other hand, I have a modeling framework which allows me to predict IC50 for those drugs. I use Spearman correlations here (so basically, one p-value for each drug); the question is: should I use FDR to correct p-values? What does it mean when I use FDR here or not?

The experimental data is something like this:

Drug name | IC50 value for cell line #1 | cell line #2 | ..... |cell line #30

M1 | 0.7|0.53|...|0.65

M2 | 0.23|0.3|...|0.37

...

M50 |1.54|1.63|...|1.35

My modeling (mathematical) approach resulted in a set of IC50 (similar to the above results, with the difference that these results are simulated/predicted and not experimental). To compare the simulation results with experimental ones, I use Spearman correlations:

Drug name | Spearman p-value

M1 | p1

M2 | p2

...

M50 | p50

So, should I correct for multiple hypothesis?

Thanks 

More Oveis Jamialahmadi's questions See All
Similar questions and discussions